Emílio Gomes

Mr. Emílio Gomes

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
EGEmílio Gomes
Emílio Gomes
TMTomás Gonçalves Mesquita
Tomás Gonçalves Mesquita
Patrícia Martins SerraPatrícia Martins Serra
Patrícia Martins Serra
Daniela AraújoDaniela Araújo
Daniela Araújo
Carina AlmeidaCarina Almeida
Carina Almeida
Joana CastroJoana Castro
Joana Castro
Antimicrobial resistance (AMR) poses a critical global public health threat, with the food chain serving as a significant transmission route connecting animals, environment, and humans. This review adopts a One Health perspective to analyze the key drivers of AMR dissemination across animal agriculture, aquaculture and food processing. We evaluate detection methodologies, contrasting the regulatory gold standard of culture-based phenotypic testing with rapid molecular advancements, including Whole Genome Sequencing (WGS), metagenomics, and emerging CRISPR-Cas diagnostics. While molecular tools offer unprecedented speed and resolution, challenges such as matrix interference, the viable but non-culturable (VBNC) state, and the genotype-phenotype disconnect remain. Finally, integrated mitigation strategies are also described, ranging from on-farm antimicrobial stewardship and innovative biofilm control to consumer hygiene practices. It is essential to bridge the technical and regulatory gaps in AMR surveillance in order to develop effective interventions and ensure a safer food system.

21 October 2026 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
EGEmílio Gomes
Emílio Gomes
RFRicardo J. Figueiredo
Ricardo J. Figueiredo
JMJoão R. Mesquita
João R. Mesquita
CACarina Almeida
Carina Almeida
DADaniela Araújo
Daniela Araújo
JCJoana Castro
Joana Castro
Whole-genome sequencing (WGS) has substantially improved the detection and surveillance of antimicrobial resistance (AMR) by enabling the rapid identification of acquired resistance genes, resistance-associated point mutations, and mobile genetic elements. However, the presence of a resistance determinant does not necessarily establish its functional contribution to the antimicrobial phenotype. This mini-review argues that a central limitation of current genotype-to-phenotype prediction is representational: multidimensional resistance architectures are frequently reduced to binary presence–absence profiles. Such representations disregard gene integrity, expression state, promoter architecture, copy number, genomic localization, regulatory topology, strain background, and within-isolate population heterogeneity. Using functionally silent determinants, pseudogenized resistance genes, inducible and dosage-dependent resistance, altered permeability and efflux, heteroresistance, and genomic-context dependence as examples, we examine how this loss of biological information can generate both false-resistant and false-susceptible predictions. We further discuss why metagenomic ARG detection cannot be directly equated with phenotypic resistance and why prediction models trained on restricted clinical populations may not generalize across species, lineages, and One Health compartments. Moving from determinant detection toward context-aware and quantitative phenotype prediction will require the selective integration of long-read sequencing, transcriptomics, copy-number analysis, population-aware sequencing, standardized phenotypic metadata, and externally validated computational models. The relevant unit of AMR prediction is therefore not the resistance gene alone, but its functional state within a specific genomic, cellular, population, and environmental context.